Hubs
About
Live
Leaderboard
Join today and earn 25 RSC
What is ResearchCoin?
0
0

Anlotinib overcomes multiple drug resistant of the colorectal cancer cells via inactivating PI3K/AKTpathway

Authors:
Weilan Lan, et al
Published:
Oct 2019
Retrieved From:biorxiv
Support
Comments0
Comments
Tweets

Paper PDF